Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT05795101
TRUDI: TDXD+Durva in HER2+/Low IBC
63
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE2)
Invasive Breast Cancer
Inflammatory Breast Cancer Stage III
HER2-positive Breast Cancer
HER2 Low Breast Adenocarcinoma
Breast Cancer
ACTIVE_NOT_RECRUITING
NCT07113054
A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of Edoxaban
14
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Healthy
COMPLETED
NCT06504719
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
312
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Breast Cancer
Metastatic Cancer
RECRUITING
NCT06145308
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
39
Enrollment(s)
2
Study location(s)
INTERVENTIONAL (PHASE2)
Salivary Gland Carcinoma
Precision Therapy
RECRUITING
NCT07157852
The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia
362
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (NA)
Fibromyalgia
Pregabalin
Mirogabalin
Pain
NOT_YET_RECRUITING
NCT07130344
PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer
262
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (NA)
Metastatic Breast Cancer
HER 2 Low-expressing Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04739761
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
506
Enrollment(s)
81
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04488822
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
40
Enrollment(s)
9
Study location(s)
INTERVENTIONAL (PHASE3)
Tenosynovial Giant Cell Tumor
11
12
13
14
15